"A gamechanging injection to prevent HIV is set to be approved for use in England and Wales. The long-acting jab, administered every two months, will offer an alternative to the daily pills used to protect against the virus. This form of HIV prevention therapy, known as PrEP (pre-exposure prophylaxis), is typically taken by HIV-negative people to reduce their risk of infection."
"The health secretary, Wes Streeting, said the approval of the injection was gamechanging. For vulnerable people who are unable to take other methods of HIV prevention, this represents hope, he said. We're making real progress on HIV, with PrEP use up by 8% this year, and our ambition goes even further. England will be the first country to end HIV transmissions by 2030, and this breakthrough treatment is another powerful tool in our arsenal to reach that crucial goal."
Cabotegravir (CAB-LA), a long-acting injectable PrEP administered every two months, has been recommended for adults and young people at risk of HIV who cannot take oral PrEP. The injection will provide an alternative to daily pills and is already available on the NHS in Scotland. Approval in England and Wales is expected with rollout beginning about three months after final guidance. More than 111,000 people accessed PrEP in England in 2024, a 7% increase, while PrEP use rose 8% this year. Around 1,000 people unable to use oral PrEP are expected to benefit annually from the new option.
Read at www.theguardian.com
Unable to calculate read time
Collection
[
|
...
]